The cost-effectiveness of testing for NS5a resistance-associated polymorphisms at baseline in genotype 1a-infected (treatment-naïve and treatment-experienced) subjects treated with all-oral elbasvir/grazoprevir regimens in the United States
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The cost-effectiveness of testing for NS5a resistance-associated polymorphisms at baseline in genotype 1a-infected (treatment-naïve and treatment-experienced) subjects treated with all-oral elbasvir/grazoprevir regimens in the United States
Authors
Keywords
-
Journal
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 45, Issue 3, Pages 455-467
Publisher
Wiley
Online
2016-12-02
DOI
10.1111/apt.13882
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment With Ledipasvir and Sofosbuvir
- (2016) Christoph Sarrazin et al. GASTROENTEROLOGY
- Systematic Review of Modelling Approaches for the Cost Effectiveness of Hepatitis C Treatment with Direct-Acting Antivirals
- (2016) Jagpreet Chhatwal et al. PHARMACOECONOMICS
- Addressing the Challenges of Hepatitis C Virus Resistance and Treatment Failure
- (2016) Che Colpitts et al. Viruses-Basel
- Cost-effectiveness of all-oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection
- (2015) Z. M. Younossi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection
- (2015) Stefan Zeuzem et al. ANNALS OF INTERNAL MEDICINE
- Role of Serologic and Molecular Diagnostic Assays in Identification and Management of Hepatitis C Virus Infection
- (2015) Gavin Cloherty et al. JOURNAL OF CLINICAL MICROBIOLOGY
- P0773 : The prevalence and the effect of HCV NS5A resistance associated variants in subjects with compensated cirrhosis treated with ledipasvir/sofosbuvir +/- RBV
- (2015) C. Sarrazin et al. JOURNAL OF HEPATOLOGY
- Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)
- (2015) Marc Bourlière et al. LANCET INFECTIOUS DISEASES
- Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial
- (2015) Masashi Mizokami et al. LANCET INFECTIOUS DISEASES
- Theoretical Foundations and Practical Applications of Within-Cycle Correction Methods
- (2015) Elamin H. Elbasha et al. MEDICAL DECISION MAKING
- Resistance-Associated NS5A Variants of Hepatitis C Virus Are Susceptible to Interferon-Based Therapy
- (2015) Jun Itakura et al. PLoS One
- Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
- (2014) Nezam Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
- (2014) Nezam Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
- (2014) Kris V. Kowdley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study
- (2013) Shannon Allen Ferrante et al. BMC INFECTIOUS DISEASES
- Treatment of Hepatitis C Virus Infection Among People Who Are Actively Injecting Drugs: A Systematic Review and Meta-analysis
- (2013) Esther J. Aspinall et al. CLINICAL INFECTIOUS DISEASES
- Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
- (2013) Adriaan J. van der Meer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial
- (2013) Eric Lawitz et al. LANCET
- Cost-Effectiveness of Boceprevir in Patients Previously Treated for Chronic Hepatitis C Genotype 1 Infection in the United States
- (2013) Jagpreet Chhatwal et al. VALUE IN HEALTH
- Cost-Effectiveness Analysis of Boceprevir for the Treatment of Chronic Hepatitis C Virus Genotype 1 Infection in Portugal
- (2013) Elamin H. Elbasha et al. Applied Health Economics and Health Policy
- A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis
- (2012) Roberta D'Ambrosio et al. HEPATOLOGY
- Chronic hepatitis C virus (HCV) disease burden and cost in the United States
- (2012) Homie Razavi et al. HEPATOLOGY
- State-Transition Modeling
- (2012) Uwe Siebert et al. MEDICAL DECISION MAKING
- Impact of adverse events on costs and quality of life in protease inhibitor-based combination therapy for hepatitis C
- (2012) Xin Gao et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Trends in Organ Donation and Transplantation in the United States, 1999-2008
- (2010) R. A. Wolfe et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Liver Transplantation in the United States, 1999-2008
- (2010) P. J. Thuluvath et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Direct Economic Burden of Chronic Hepatitis C Virus in a United States Managed Care Population
- (2010) Keith L. Davis et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus
- (2010) Masakuni Tateyama et al. JOURNAL OF GASTROENTEROLOGY
- Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: Incidence and survival in hepatitis C patients with advanced fibrosis
- (2010) Ana-Carolina Cardoso et al. JOURNAL OF HEPATOLOGY
- Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression
- (2009) Gary L. Davis et al. GASTROENTEROLOGY
- High incidence of hepatitis C virus reinfection in a cohort of injecting drug users
- (2008) Campbell Kynoch Aitken et al. HEPATOLOGY
- Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression
- (2008) Hla-Hla Thein et al. HEPATOLOGY
- The burden of illness associated with hepatocellular carcinoma in the United States
- (2008) Kathleen Lang et al. JOURNAL OF HEPATOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started